Latest stroke Stories
Daily aspirin is recommended for those with existing cardiovascular disease.
Patient Enrollment Process to begin in Southern California for expanding indications of the NobleStitch EL™ Suture Closure of PFO “Patent Forman Ovale” and the repair of Iatrogenic ASD “Atrial
Eli Lilly failed to warn that the testosterone replacement drug, Axiron, may increase the risk of heart attack and stroke, a lawsuit filed in federal court alleges.
World Thrombosis Day launches to bring awareness to largely preventable disease as comprehensive science review and public survey reveal large gap in public's knowledge CHAPEL HILL, N.C., Oct.
Saint Luke's becomes third in Missouri and 78th in the nation to be recognized for offering specialized care to patients with the most severe and challenging types of stroke Kansas
Comprehensive Clinical Data from Randomized Trials Reviewed MARLBOROUGH, Mass., Oct.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients
As Testosterone Complaints Continue to Increase, the FDA Furthers Its Investigation into Testosterone Use by Holding a Meeting of Its Advisory Panels to Explore the Safety and Effectiveness of
HELSINKI, October 2, 2014 /PRNewswire/ -- Nexstim Oy ("Nexstim" or the "Company"), a medical technology company aiming to improve rehabilitation for stroke patients through
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...
- A political dynamiter.
More Images (3 images) »